Share

|

|

|

LAMP2: Atropine eyedrops may reduce myopia incidence in children

Children using nightly atropine eyedrops have a significantly lower incidence of myopia during 2 years of use than those using placebo, show the findings of the LAMP2 randomised trial.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Impaired motor development flags psychosis risk in susceptible children

Children with a high familial risk of psychosis have an increased risk of motor impairments, which are stable over time and linked to the likelihood of having psychotic experiences, research shows.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Long COVID risk small in children

Researchers find a high burden of non-specific persistent symptoms in children aged 14 years or younger, with SARS-CoV-2 infection adding to this only slightly.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.